Medicare costs could soar with availability of new obesity drugs, experts say
By
Alicia Lasek
Mar 15, 2023
If efforts are successful to expand Medicare Part D to cover these drugs, premiums could soar, according to economists with Vanderbilt University and the University of Chicago.
CDC says hospital data will keep healthcare providers on top of COVID-19
By
Alicia Lasek
May 11, 2023
As the public health emergency ends, new surveillance will help keep healthcare providers informed about disease trends and prepared for outbreaks, the agency says.
Common infections linked to reduced cognitive test scores for older adults
By
Alicia Lasek
Apr 23, 2023
Common infections, including with the herpes simplex virus, are associated with reduced performance on a test of global function, researchers from Johns Hopkins University report.
Expanded methadone access urged for SNF residents with opioid use disorder
By
Alicia Lasek (f3)
Jul 28, 2022
Policy changes are needed to help to improve older adults’ recovery rates in the skilled nursing facility population, according to a call for regulatory reform published Tuesday.
FDA: Evusheld may be less effective against latest COVID variants
By
Alicia Lasek
Oct 05, 2022
Evusheld, a preventive COVID-19 antibody for high-risk patients, may lose efficacy in the face of newly emerging variants, the FDA has informed clinicians.
GAO report finds ‘deficiencies’ in HHS’s handling of PHEs
May 15, 2023
Over a decades’ time, these issues have affected the nation’s response not only to COVID-19, but to past public health emergencies including the H1N1 influenza pandemic and extreme weather events...
Feds must ramp up efforts against antibiotic resistance: GAO
By
Alicia Lasek
Apr 27, 2023
Federal health agencies must urgently tackle key measures of a plan to curb the rising threat of antibiotic-resistant organisms, according to new testimony released by the Government Accountability Office...
CMS shares new coverage details for Alzheimer’s drug Leqembi
By
Alicia Lasek
Jun 26, 2023
On the eve of an FDA decision, CMS has released new information about the detailed patient data that clinicians must provide to ensure Medicare coverage when prescribing Leqembi.
CDC: Superbugs have spread beyond the long-term care setting
By
Alicia Lasek (f3)
Aug 02, 2022
An increase in community-associated multi-drug-resistant infections is troubling, investigators say.
Opioid prescribing info updated, adverse reactions flagged
By
Alicia Lasek
Apr 18, 2023
The FDA has made several updates to its opioid prescribing information, including new warnings about increased pain that can lead to adverse reactions such as respiratory depression.